Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.7 CAD | +4.94% | +0.59% | -49.25% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
William Rice
CEO | Chief Executive Officer | 65 | 13-10-27 |
C. Payne
DFI | Director of Finance/CFO | 61 | 22-06-26 |
Chief Tech/Sci/R&D Officer | - | 19-10-31 | |
Rafael Bejar
CTO | Chief Tech/Sci/R&D Officer | 53 | 19-12-31 |
Investor Relations Contact | - | - | |
Marc Wiles
LAW | General Counsel | - | - |
Brooks Ensign
AUD | Comptroller/Controller/Auditor | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Denis Burger
BRD | Director/Board Member | 80 | 07-09-18 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 22-09-12 |
Mark Vincent
BRD | Director/Board Member | 71 | 07-09-18 |
Director/Board Member | 74 | 14-12-14 | |
William Rice
CEO | Chief Executive Officer | 65 | 13-10-27 |
Warren Whitehead
BRD | Director/Board Member | 71 | 11-04-06 |
Carol Ashe
BRD | Director/Board Member | 66 | 18-08-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 15,717,701 | 12,619,162 ( 80.29 %) | 0 | 80.29 % |
Company contact information
Aptose Biosciences, Inc.
251 Consumers Road Suite 1105
M2J 4R3, Toronto
+647 479 9828
http://www.aptose.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.25% | 19.52M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- APS Stock
- Company Aptose Biosciences Inc.